eagle-i University of Hawaii at ManoaUniversity of Hawaii at Manoa
See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

Randomized phase III trial comparing 16 to 18 weeks of neoadjuvant exemestane (25 mg daily), letrozole (2.5 mg), or anastrozole (1 mg) in postmenopausal women with clinical stage II and III estrogen receptor positive breast cancer

eagle-i ID

http://hawaii.eagle-i.net/i/00000130-dd85-c825-9953-50a980000000

Resource Type

  1. Clinical trial

Properties

  1. ClinicalTrials.gov url
    http://www.clinicaltrials.gov/ct2/show/NCT00265759?term=ACOSOG-Z1031&rank=1
  2. Intervention
    Anastrozole
  3. Intervention
    Exemestane
  4. Intervention
    Letrozole
  5. Additional Topic(s)
    Antineoplastic combined chemotherapy protocols
  6. Resource Description
    It is not yet known whether exemestane, letrozole, or anastrozole is more effective in treating breast cancer. This randomized phase III trial is studying exemestane, letrozole, and anastrozole to compare how well they work in treating postmenopausal women who are undergoing surgery for stage II or stage III breast cancer.
  7. Contact
    Berenberg, Jeffrey
  8. PI
    Berenberg, Jeffrey
  9. Topic
    breast cancer
  10. Study Population
    Females with measurable disease, no inflammatory breast cancer, estrogen receptor positive tumor, and no previous radiation therapy, hormone therapy, or chemotherapy for invasive breast cancer.
  11. Website(s)
    http://www.cancer.gov/clinicaltrials/featured/trials/acosog-z1032
  12. Website(s)
    http://www.cancer.gov/clinicaltrials/search/view?cdrid=456382&version=healthprofessional
  13. Funded by
    Cancer Trials Support Unit
  14. Phase
    Phase 2 clinical trial
  15. Performed by
    Clinical Protocol & Data Management Shared Resource
 
RDFRDF
 
Provenance Metadata About This Resource Record
Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016